Authors
Latest:
From Concept to Commercialization: Pushing the EnvelopeDisruptive strategies are essential to grow the pharma industry.
Latest:
Environmental Sustainability in the Life Sciences Sector: Embedding ChangeFor many years, high energy use and its impact on the environment by businesses within the life sciences sector had been generally overlooked in national and global efforts to combat climate change. But with “carbon neutrality” the new buzzwords, how is the sector embracing this push for change?
Latest:
Out-licensing Deals Between Chinese Pharma and Global Companies are Heating UpA growing number of domestic drug developers are setting their sights on overseas markets.
Latest:
Paving the Path to IPO: How to Build Compliant Financial Systems and ProcessesThursday, April 28, 2022 at 11am PDT | 2pm EDT Are you ready for the challenges of going public? Whether you are a fast-growing biotech company or are currently public and looking for SOX compliance, this webinar will cover how to set up scalable and compliant financial processes.
Latest:
Reimagine Thought Leader Identification: Finding Enrollers and EducatorsKey opinion leaders may not be hard to find, but they are very hard to engage because everybody wants a piece of them.
Latest:
Changing the Paradigm in AI ImplementationHow pharma companies can reduce the risk of failure with AI-based innovations.
Latest:
The Price of Prescriptions: Getting it RightDrug companies face new hurdles in a rapidly changing marketplace. How do they finance new drug development amid the uncertainty?
Latest:
Patient Treatment & Travel: The Need for Stepped-Up SupportDesigning an effective travel and lodging patient hub program in pharma.
Latest:
Equity for Women in Healthcare: 131 Years is Too Long to WaitClosing the gender gap in pharma—and how we get there together.
Latest:
Asia Embracing New Technologies for Better HealthcareThe region is moving to the forefront in integrating therapeutic innovation.
Latest:
Industry Predictions For 2023Top industry experts weigh in on what the new year holds for the pharma industry.
Latest:
How Bringing Pharmacovigilance In-House Drives Better Oversight and Faster Data AnalysisFor companies in the life science industry, managing their processes in house on their own platforms proved beneficial.
Latest:
Technology Overload: Addressing Site Challenges of Digital TrialsWebinar Date/Time: Wednesday, August 30, 2023 at 11am EDT
Latest:
3 Reasons US Payers Will Make 2021 a Banner Year for BiosimilarsFollowing a year which saw a 143% increase in launched biosimilars in the US, here are three reasons why payers will drive adoption further in 2021.
Latest:
Measuring Pharma’s Wider MandateEspecially critical amid the continuing global pandemic, key metrics are laid out to help life sciences companies define, measure, and effectively communicate sustainability practices and progress—and build foundations for long-term business value.
Latest:
Strategies for Success in an Evolving Commercialization LandscapeA phased launch approach may ultimately be more sustainable and enable maximum market penetration and commercial success with less upfront investment than traditional “go-for-broke” strategies.
Latest:
Embracing Digital Education During COVID-19 CrisisAs the world of medicine continues to face the impact of the COVID-19 pandemic, clinicians are increasingly looking to digital solutions, including continuing medical education (CME), to stay current on the latest developments in their field.
Latest:
Advancing Health Innovation in 2022: Where Should We Focus?What can both public and private sector stakeholders learn from current trends to accelerate innovation around the COVID-19 pandemic and other emerging global health threats, including antimicrobial resistance?
Latest:
How Digital Twins Drive Sustainability in Clinical Supply PlanningEmerging technologies like digital twins offer supply chain efficiency solutions, allowing the industry to integrate sustainable practices while ensuring patient safety.
Latest:
NFTs: What This New Kid on the Blockchain Means for HealthcareThere has been a push to implement NFTs, or non-fungible tokens, across many verticals, but there is still much to learn about their potential uses in healthcare and its brands.
Latest:
How GxP Leaders Can Assess and Approach a Company’s Quality CultureUsing the interview process to ensure high organizational standards.
Latest:
Securing the Safety Net in Drug Access and SupportA look at the intersection of rigorous compliance and ethical behavior: independent, charitable patient assistance foundations.
Latest:
Next-level Efficacy: MounjaroDual-targeted injection poised to rock GLP-1 field in diabetes—and eventually weight loss.
Latest:
Top Five Trends in Life Sciences Compliance for 2022Patient protection and social influence among trends to look out for as calendar turns.
Latest:
FDA Approves Rybrevant for Locally Advanced, Metastatic Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung CancerRybrevant is the first targeted second-line regimen to significantly reduce the risk of disease progression by more than 50% in patients with locally advanced or metastatic EGFR mutated non-small cell lung cancer, according to Johnson & Johnson.
Latest:
Virtual Medical Affairs Audits: A Viable AlternativeVirtual audits proving to be beneficial post-COVID despite continuing challenges.
Latest:
The Case for Market Access...Early and OftenIndustry veteran Ken Abreu makes the case for approaching market access very early in the process, and elucidates why it's so important.
